Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shenzhen Lifotronic Technology Co PB Ratio?
Shenzhen Lifotronic Technology CoSHSE:688389 -3.12%89 PB Ratio is 2.04 as of Jul. 24, 2026, which is 65% below its 10-year median of 5.77. GuruFocus rates SHSE:688389 with a GF Score™ of 89/100 and a GF Value™ of ¥15.70 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Shenzhen Lifotronic Technology Co ranks worse than 50.89% on this metric.
SHSE:688389'
s PB Ratio Range Over the Past 10 Years
Min: 1.91 Med: 5.77 Max: 13.59
Current: 2.04
During the past 10 years, Shenzhen Lifotronic Technology Co's highest PB Ratio was 13.59. The lowest was 1.91. And the median was 5.77.
SHSE:688389's PB Ratio is ranked worse than 50.89% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2
vs SHSE:688389: 2.04
During the past 12 months, Shenzhen Lifotronic Technology Co's average Book Value Per Share Growth Rate was 2.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 13.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 14.20% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Shenzhen Lifotronic Technology Co was 36.50% per year. The lowest was 11.10% per year. And the median was 17.20% per year.
Back to Basics: PB Ratio
Shenzhen Lifotronic Technology Co (SHSE:688389) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Shenzhen Lifotronic Technology Co PB Ratio Related Terms
Shenzhen Lifotronic Technology Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Shenzhen Lifotronic Technology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Lifotronic Technology Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Lifotronic Technology Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Shenzhen Lifotronic Technology Co's PB Ratio falls into.
Shenzhen Lifotronic Technology Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shenzhen Lifotronic Technology Co (SHSE:688389) has a PB Ratio of 2.04 as of Jul. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shenzhen Lifotronic Technology Co and its competitors. This is 65% below median its historical median of 5.77. Over the past decade, Shenzhen Lifotronic Technology Co's PB Ratio has ranged from 1.91 to 13.59. According to the industry distribution chart, Shenzhen Lifotronic Technology Co ranks #400 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 50.9%.
Is Shenzhen Lifotronic Technology Co's PB Ratio too high?
Shenzhen Lifotronic Technology Co's current PB Ratio of 2.04 is 65% below median its 10-year median of 5.77. Over the past 10 years, this metric has ranged from a low of 1.91 to a high of 13.59. The Medical Devices & Instruments industry median PB Ratio is 2.00. Shenzhen Lifotronic Technology Co's value of 2.04 is 2% above this industry median. Based on the distribution chart, Shenzhen Lifotronic Technology Co ranks #400 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shenzhen Lifotronic Technology Co has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Lifotronic Technology Co's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Lifotronic Technology Co ranks #400 out of 786 companies for PB Ratio. This places Shenzhen Lifotronic Technology Co in the lower half of its industry. The industry median PB Ratio is 2.00. Shenzhen Lifotronic Technology Co's value of 2.04 is 2% above this benchmark. Historically, Shenzhen Lifotronic Technology Co's own PB Ratio has ranged from 1.91 to 13.59 over the past decade. While the company's 10-year median is 5.77 vs. the industry median of 2.00, Shenzhen Lifotronic Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.00, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Lifotronic Technology Co's current PB Ratio of 2.04 is 2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shenzhen Lifotronic Technology Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Lifotronic Technology Co's current PB Ratio is 2.04, which is 65% below median its own 10-year median of 5.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Lifotronic Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Lifotronic Technology Co (SHSE:688389) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥15.70, compared to a current price of ¥10.24 — trading 34.8% below its estimated fair value. The current PB Ratio is 2.04, which is 65% below median its 10-year median of 5.77 and 2% above the Medical Devices & Instruments industry median of 2.00. Shenzhen Lifotronic Technology Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shenzhen Lifotronic Technology Co (SHSE:688389), the current PB Ratio is 2.04 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen Lifotronic Technology Co (SHSE:688389) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen Lifotronic Technology Co stock appears to be undervalued.
The current stock price of ¥10.24 is trading 34.8% below its estimated GF Value™ of ¥15.70.
GuruFocus considers Shenzhen Lifotronic Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688389:
PB Ratio: 2.04 (65% below median its 10-year median of 5.77)
GF Value™: ¥15.70 vs. price of ¥10.24 (34.8% below fair value)
Industry Position: 2% above the Medical Devices & Instruments median (#400 of 786)
No single metric tells the full story. See the SHSE:688389 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen Lifotronic Technology Co Business Description
Shenzhen Lifotronic Technology Co Ltd is a China based company engaged in the development, production and sales of therapeutic and rehabilitation products, in vitro diagnostic equipment and supporting reagents.
89GF Score
Get the complete analysis for SHSE:688389
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688389 has been successfully added to your 
